|
|
|
|
| Reserve your space for our Virtual Symposium on October 08! Moderated by Dr. Eleni Samaridou, Principal Scientist, Early Formulation Screening Service at MilliporeSigma, the symposium will feature Dr. Roland Böttger, Senior Scientist at CureVac, and other industry experts. Presentations will outline utilizing isolator filling technology for LNP manufacturing, navigating regulations for quality control testing of mRNA/LNP products and tailoring the immunogenicity profile in an mRNA-LNP vaccine platform to extend the shelf-life stability. Register now! |
|
|
|
|
By Irwin Hirsh, Q-Specialists AB | Poor knowledge management delays regulatory approval and, thus, market access. Here's the first in a series examining the complexity of knowledge management for CMC and across the value stream. |
|
|
|
|
|
| Cryopreservation Best Practices For CGT Source Material | Webinar | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters. |
|
|
| Advantages Of Cas9 mRNA For Gene Editing | Article | Vernal Biosciences | Discover why Cas9 mRNA is the preferred choice for precise gene editing, offering efficient delivery, transient expression, and flexible targeting. |
|
|
|
|
|
| Personalized Cancer Vaccine Summit | With landmark trials underway with BioNTech and Moderna's personalized mRNA cancer vaccines, the Personalized Cancer Vaccine Summit is the only conference uniting biopharma companies working on different vaccine modalities to develop an immune-responsive personalized cancer vaccine for one goal — cure cancer! Download the full event guide to learn more about what's in store! |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
